MENU
  • About Us
  • Our Science
    • HSO-001
    • Sublingual immunotherapy
  • News
  • Contact
  • en_USEnglish
    • ja日本語
We contribute to people's health by developing new allergen immunotherapy.
HISHOH Biopharma
  • About Us
  • Our Science
    • HSO-001
    • Sublingual immunotherapy
  • News
  • Contact
  • en_USEnglish
    • ja日本語
HISHOH Biopharma
  • About Us
  • Our Science
    • HSO-001
    • Sublingual immunotherapy
  • News
  • Contact
  • en_USEnglish
    • ja日本語
  1. Home
  2. MEDIA
  3. Nikkei Biotech published an article about our company

Nikkei Biotech published an article about our company

2022 1/12
MEDIA
January 12, 20222026年8月8日

「日経バイオテク」に当社に関する記事が掲載。

MEDIA
  • Execution of a license agreement for a substance with immunostimulatory properties and implementation of a third-party allocation of new shares in the seed round
  • HISHOH Biopharma was introduced on the LINK-J website.

Author of this article

hishohのアバター hishoh

関連記事

  • HISHOH Logo
    HISHOH Biopharma was introduced on the LINK-J website.
    March 6, 2023

© HISHOH Biopharma.

TOC